oxazoles has been researched along with Central Nervous System Infection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galabov, AS; Nikolova, I; Stoyanova, A | 1 |
| Apewokin, SK; Mathur, P; Matin, A; Sharma, S | 1 |
| Harvala, H; Pajkrt, D; Wildenbeest, JG; Wolthers, KC | 1 |
1 review(s) available for oxazoles and Central Nervous System Infection
| Article | Year |
|---|---|
The need for treatment against human parechoviruses: how, why and when?
Topics: Animals; Antiviral Agents; Central Nervous System Infections; Disease Models, Animal; Humans; Infant, Newborn; Oxadiazoles; Oxazoles; Parechovirus; Picornaviridae Infections; Sepsis | 2010 |
2 other study(ies) available for oxazoles and Central Nervous System Infection
| Article | Year |
|---|---|
Effect of consecutive alternating administration (CAA) of a triple anti-enteroviral combination on Coxsackievirus B1 neuroinfection in mice.
Topics: Animals; Antiviral Agents; Apomorphine; Brain; Central Nervous System Infections; Coxsackievirus Infections; Disease Models, Animal; Drug Resistance, Viral; Drug Therapy, Combination; Enterovirus B, Human; Guanidine; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Survival Analysis; Treatment Outcome | 2015 |
Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Brain; Central Nervous System Infections; Debridement; Female; Florida; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Myeloma; Nocardia; Nocardia Infections; Organophosphates; Oxazoles; Treatment Outcome | 2017 |